Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options.
about
Therapeutic Application of Synbiotics, a Fusion of Probiotics and Prebiotics, and Biogenics as a New Concept for Oral Candida Infections: A Mini ReviewCandida albicans Biofilms and Human DiseaseFungal iron availability during deep seated candidiasis is defined by a complex interplay involving systemic and local eventsEvolution and Application of Inteins in Candida species: A ReviewUltrastructural analysis of Candida albicans when exposed to silver nanoparticlesPhenolic composition and medicinal usage of Psidium guajava Linn.: Antifungal activity or inhibition of virulence?Caspofungin-Non-Susceptible Candida orthopsilosis Isolated from Onychomycosis in Iran.Isolation, speciation and antifungal susceptibility testing of Candida isolates from various clinical specimens at a tertiary care hospital, Nepal.Characterization and identification of candiduria due to Candida species in diabetic patients.An investigation of the inhibitory effects of dendrosomal nanocurcumin on Candida albicans and systemic candidiasis in BALB/c mice.Formulation and candidacidal activity of magnetic nanoparticles coated with cathelicidin LL-37 and ceragenin CSA-13.Antifungal drug discovery: the process and outcomes.Antifungal activity of topical microemulsion containing a thiophene derivative.Rasamsonia argillacea species complex: taxonomy, pathogenesis and clinical relevance.Non-albicans Candida Infection: An Emerging ThreatSmall-molecule suppressors of Candida albicans biofilm formation synergistically enhance the antifungal activity of amphotericin B against clinical Candida isolates.Comparison Between Virulence Factors of Candida albicans and Non-Albicans Species of Candida Isolated from Genitourinary Tract.Plant-derived decapeptide OSIP108 interferes with Candida albicans biofilm formation without affecting cell viabilityLipopeptides from Bacillus strain AR2 inhibits biofilm formation by Candida albicans.In vitro characterization of Trichophyton rubrum and T. mentagrophytes biofilms.The Effect of Essential Oils and Bioactive Fractions on Streptococcus mutans and Candida albicans Biofilms: A Confocal Analysis.Antifungal activity of amphotericin B and voriconazole against the biofilms and biofilm-dispersed cells of Candida albicans employing a newly developed in vitro pharmacokinetic model.Microbial colonization of irradiated pathogenic yeast to catheter surfaces: Relationship between adherence, cell surface hydrophobicity, biofilm formation and antifungal susceptibility. A scanning electron microscope analysis.Overexpression of Both ERG11 and ABC2 Genes Might Be Responsible for Itraconazole Resistance in Clinical Isolates of Candida krusei.Fibronectin-, vitronectin- and laminin-binding proteins at the cell walls of Candida parapsilosis and Candida tropicalis pathogenic yeasts.Multilocus microsatellite analysis of European and African Candida glabrata isolates.Inhibitory Effect of Sophorolipid on Candida albicans Biofilm Formation and Hyphal Growth.Lindgomycin, an Unusual Antibiotic Polyketide from a Marine Fungus of the Lindgomycetaceae.Treatment of Oral Candidiasis Using Photodithazine®- Mediated Photodynamic Therapy In Vivo.Molecular analysis of fungal populations in patients with oral candidiasis using next-generation sequencing.Host-Imposed Copper Poisoning Impacts Fungal Micronutrient Acquisition during Systemic Candida albicans InfectionsDelicate Metabolic Control and Coordinated Stress Response Critically Determine Antifungal Tolerance of Candida albicans Biofilm Persisters.Analysis of oral yeast microflora in patients with oral squamous cell carcinoma.Candida tropicalis biofilm and human epithelium invasion is highly influenced by environmental pH.Virulence factors of fluconazole-susceptible and fluconazole-resistant Candida albicans after antimicrobial photodynamic therapy.Characterization of a novel antibiofilm effect of nitric oxide-releasing aspirin (NCX-4040) on Candida albicans isolates from denture stomatitis patients.From Biology to Drug Development: New Approaches to Combat the Threat of Fungal BiofilmsBiofilm formation is a risk factor for mortality in patients with Candida albicans bloodstream infection-Scotland, 2012-2013.Manipulation of Host Diet To Reduce Gastrointestinal Colonization by the Opportunistic Pathogen Candida albicansExploring ecological modelling to investigate factors governing the colonization success in nosocomial environment of Candida albicans and other pathogenic yeasts.
P2860
Q26772729-479AEA8C-1398-49AC-935E-52C5EAD14545Q26778729-78E87B94-3706-4CDD-B600-13C9913D8015Q27332296-11F15C97-B5A4-4F7A-8CDE-635CC3A34CE7Q28078765-F11C59D7-F51D-4AAC-A1E1-B953F4F968F7Q28543581-AB6046FB-4165-4448-9B19-7E761E63DED3Q28817992-B7C88502-6C33-4CA5-AFE3-3D38C864DC52Q33596063-6AC76518-21A0-475C-956D-CF1EE6370F8CQ33830994-66DFEDD8-6A14-4462-8045-673985E5B119Q33851284-C5E79012-A622-4B1D-AE72-0E7557D18E8DQ33851306-A6ECD18D-3237-4B4C-89EE-1594C8C5316AQ33870762-B2F21C40-C245-4BD5-B80F-B92D6261B99CQ34086897-5C47F0F1-2CDC-4964-A177-3C111583D20BQ34198347-3AEE07F2-2795-480E-8020-4744DC903DCFQ34360893-F7B231AF-AF9D-4C56-A459-180F4675E3C4Q34488096-F96DF7BC-CA66-49EA-A708-935DF95F03C1Q34578357-1AC94EBE-991E-4512-A66E-D26A2E21169BQ34909936-07B7095C-0A0A-43BC-BDF0-2EF62A0BE7B6Q35102365-BD4B2C9A-45C4-45F8-A869-345A3C6AF6E3Q35119233-047E3606-EAF7-456F-A641-DC84DC6E6961Q35173071-42B774A3-DC78-4F63-983F-7E2F8451E46EQ35188272-4076EB43-77DE-4176-B513-565C4C277618Q35318531-63506BDD-8BB6-4F0D-87EE-A66836811343Q35574796-4E19DF36-F03B-4C24-9EF2-CFE7F669C91BQ35756098-A2D0F6CE-D681-4F6B-B412-530A8599559EQ35799819-37487C88-7242-43A6-A3EE-43A20A6382A4Q35946831-321DA4F4-08EB-4488-947F-105E09794B38Q35974693-6DB7DC43-1871-4C71-B231-41E1BB81EE04Q36017979-D9EBB430-C848-4255-ADD0-CF776CCD9754Q36038009-3EBBBEA3-D2FF-4550-BD8F-990B15724D5FQ36053286-F50A2FB7-877E-477B-B207-AF42CB535A5BQ36064900-ABC23016-0EB9-4A5A-81E6-D49031DA903EQ36075939-36F63B20-957C-4240-AB2D-20A159B55EE7Q36106522-918CD2C0-0C0E-43C2-A860-B32371DF423EQ36153026-72062649-1FE1-478A-B222-B31DEB9544EAQ36303753-D7A58E92-1461-4A9F-A780-BBD67FB09900Q36368948-1D1BA4CD-F1F8-4A34-A4CE-DCC5134E2FBBQ36422270-3FA9DDB3-78C5-4290-8454-5A59DD1BC10AQ36486984-5CA3680E-5967-4FF7-AB37-5CAE5FA2584AQ36891368-4605C6F4-5CD3-498D-B41C-642F3957C01BQ36953947-147DE682-E50D-4710-9880-96210603976D
P2860
Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options.
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Candida species: current epide ...... s and new therapeutic options.
@ast
Candida species: current epide ...... s and new therapeutic options.
@en
Candida species: current epide ...... s and new therapeutic options.
@nl
type
label
Candida species: current epide ...... s and new therapeutic options.
@ast
Candida species: current epide ...... s and new therapeutic options.
@en
Candida species: current epide ...... s and new therapeutic options.
@nl
prefLabel
Candida species: current epide ...... s and new therapeutic options.
@ast
Candida species: current epide ...... s and new therapeutic options.
@en
Candida species: current epide ...... s and new therapeutic options.
@nl
P2093
P356
P1476
Candida species: current epide ...... ts and new therapeutic options
@en
P2093
A M Fusco-Almeida
J C O Sardi
T Bernardi
P356
10.1099/JMM.0.045054-0
P577
2012-11-22T00:00:00Z